Of interest, in patients with non-lethal COVID-19, potent virus-specific CD4+ and especially CD8+ T cell responses were observed prior to recovery from disease, indicating that cell-mediated immunity to SARS-CoV-2 is a correlate of protection5–8. This evidence concerns the gene CD8A and COVID-19.